LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond
- PMID: 35292092
- PMCID: PMC8922926
- DOI: 10.1186/s13046-022-02319-z
LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond
Erratum in
-
Correction: LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond.J Exp Clin Cancer Res. 2022 Aug 27;41(1):262. doi: 10.1186/s13046-022-02468-1. J Exp Clin Cancer Res. 2022. PMID: 36028910 Free PMC article. No abstract available.
Abstract
DNA methylation is one of the most important epigenetic mechanisms to regulate gene expression, which is highly dynamic during development and specifically maintained in somatic cells. Aberrant DNA methylation patterns are strongly associated with human diseases including cancer. How are the cell-specific DNA methylation patterns established or disturbed is a pivotal question in developmental biology and cancer epigenetics. Currently, compelling evidence has emerged that long non-coding RNA (lncRNA) mediates DNA methylation in both physiological and pathological conditions. In this review, we provide an overview of the current understanding of lncRNA-mediated DNA methylation, with emphasis on the roles of this mechanism in cancer, which to the best of our knowledge, has not been systematically summarized. In addition, we also discuss the potential clinical applications of this mechanism in RNA-targeting drug development.
Keywords: Cancer; DNA methylation; DNMT; Non-coding RNA; TET; lncRNA.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures





References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical